Pandey Avaneesh Kumar, Shafiq Nusrat, Kakkar Ashish Kumar, Malhotra Samir, Woods Beth, Little Christopher, Rhodes Tom, Tuson Harriet, Riaz Zeshan, Ashfield Tom, Corley Michael, Baltas Ioannis
Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Centre for Health Economics, University of York, York, UK.
Commun Med (Lond). 2024 Oct 11;4(1):198. doi: 10.1038/s43856-024-00594-9.
Despite the constant development of antimicrobial resistance (AMR), few new antimicrobials are currently becoming available clinically. Alternative approaches, such as different mechanisms to fund their use, are being explored to encourage development of new antimicrobials.
尽管抗菌药物耐药性(AMR)不断发展,但目前临床上可用的新型抗菌药物却很少。人们正在探索其他方法,例如采用不同机制为其使用提供资金,以鼓励新型抗菌药物的研发。